LF

본문 바로가기

Investor Relations

We are committed to increasing shareholder value through strengthening of corporate values and proactively promoting IR activities.

Income Statement

Consolidated Balance Sheet
ITEM	FY20 Q3	FY19	FY18	FY17	FY16
Noncurrent assets	19,910	16,690	15,062	12,383	11,968
Current assets	11,324	12,459	12,494	13,458	13,443
Total Assets	31,234	29,150	27,556	25,840	25,411
Controlling interest	16,064	15,717	15,281	14,689	13,349
Issued capital	1,462	1,462	1,462	1,462	1,462
Consolidated capital surplus	2,136	2,136	2,136	2,137	2,131
Consolidated capital adjustment	(515)	(358)	(186)	(186)	(160)
Consolidated retained earnings	12,931	12,430	11,886	11,294	9,948
Consolidated accumulated other comprehensive income	50	48	(16)	(19)	(32)
Non-controlling interest	2,087	2,011	1,855	1,880	1,635
Total stockholders’ equity	18,151	17,728	17,136	16,568	14,984
Noncurrent liabilities	5,700	6,471	2,258	1,844	4,296
Current liabilities	7,383	4,951	8,162	7,428	6,132
Total liabilities	13,083	11,422	10,421	9,272	10,428
Total stockholders’ equity and liabilities	31,234	29,150	27,556	25,840	25,411

Consolidated Income Statement
ITEM	FY20 Q3	FY19 Q3	FY19	FY18	FY17	FY16
Revenue	12,846	13,968	19,563	19,007	19,685	17,931
Costs of goods sold	(5,487)	(5,743)	(8,427)	(8,063)	(7,982)	(6,950)
Gross profit	7,359	8,225	11,135	10,944	11,704	10,981
Selling and administrative expenses	(6,454)	(7,224)	(9,874)	(10,370)	9,852	9,392
Operating profit	905	1001	1,261	574	1,852	1,589
Finance income	133	110	143	166	109	63
Finance costs	(247)	(240)	(303)	(225)	(104)	(127)
Other non-operating income and expense	113	110	219	243	574	736
Other non-operating expenses	(129)	(67)	(231)	(159)	(234)	(310)
Investment Income Using the Equity Method	260	52	62	29	41	42
Income before income tax expense	1,035	966	1,151	628	2,238	1,994
Income tax expense	(231)	(177)	(245)	172	(465)	(632)
Consolidated net income	804	789	906	801	1,773	1,362

Summary of Financial Statement

Separate Balance Sheet
ITEM	FY20 Q3	FY19	FY18	FY17	FY16
Noncurrent assets	14,833	13,745	12,453	12,237	10,847
Current assets	5,497	6,042	7,095	7,500	7,537
Total Assets	20,330	19,787	19,548	19,737	18,384
Issued capital	1,462	1,462	1,462	1,462	1,462
Capital surplus	2,132	2,132	2,132	2,132	2,132
Elements of other stockholder's equity	(445)	(295)	(141)	(139)	(134)
retained earnings	13,374	12,883	12,332	11,763	10,452
Other Comprehensive income/loss	29	26	(39)	(40)	(61)
accumulated amount	16,552	16,208	15,746	15,178	13,851
Noncurrent liabilities	1,315	2,148	1,244	1,268	2,428
Current liabilities	2,463	1,432	2,558	3,292	2,106
Total liabilities	3,778	3,580	3,802	4,559	4,534
Total stockholders’ equity and liabilities	20,330	19,787	19,548	19,737	18,384

Separate Income Statement
ITEM	FY20 Q3	FY19 Q3	FY19	FY18	FY17	FY16
Revenue	7,979	8,602	12,053	12,726	12,719	11,455
Costs of goods sold	(3,149)	(3,376)	(4,820)	(4,908)	(4,921)	(4,440)
Gross profit	4,830	5,226	7,233	7,818	7,798	7,015
Selling and administrative expenses	(4,306)	(4,856)	(6,575)	(7,266)	(7,040)	(6,234)
Operating profit	523	370	658	552	758	780
Finance income	92	92	117	129	107	69
Finance costs	(92)	(125)	(155)	(136)	(63)	(71)
Other non-operating income and expense	74	80	162	169	499	709
Other non-operating expenses	(75)	(45)	(111)	(90)	(185)	(83)
Using the Equity Method	303	302	213	65	595	388
Income before income tax expense	825	674	884	689	1,709	1,792
Income tax expense	(140)	(58)	(109)	134	(151)	(363)
Consolidated net income	685	616	776	823	1,558	1,430